Titan Bio-Tech Chart
Titan Bio-Tech Share Key Metrics
Volume
2.60 L
Market Cap
1983.29 CR
LTQ@LTP
40@504.00
ATP
493.76
Var Margin
100 %
Circuit Range
456-504
Delivery %
100 %
Value
12.82 CR
ASM/GSM
No
Market Lot
1
Summary
Titan Bio-Tech Fundamentals
View MoreP/E Ratio
72.9
P/B Ratio
11.38
Div. Yield
0.08
Sector P/E
34.91
Sector P/B
2.16
Sec. Div. Yield
0.55
Titan Bio-Tech Resistance and Support
Pivot 473.85
Resistance
First Resistance
486.7
Second Resistance
493.4
Third Resistance
506.25
Support
First Support
467.15
Second Support
454.3
Third Support
447.6
Titan Bio-Tech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-12 | Quarterly Results |
| 2025-11-29 | Stock Split |
| 2025-11-11 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-12 | Quarterly Results |
Titan Bio-Tech News
Titan Biotech Ltd - 524717 - Closure of Trading Window
Titan Biotech will hold a board meeting for the approval of its audited standalone and cons. financial results for the financial year ending March 31, 2026. The exact date of this meeting will be announced in due course.
Mar 26 2026 13:03:00
About Titan Bio-Tech
NSE : 0
BSE : 524717
ISIN : INE150C01029
Titan Medicares Ltd. (hereinafter referred to as "TheCompany" or TML) was incorporated as a public limitedcompany on 18th February 1992 under the Companies Act1956 and obtained the certificate of Commencement ofBusiness on 25th February 1992 from the Registrar ofCompanies Delhi & Haryana at New Delhi. The Company ishaving its Registered Office at 408 Vikram Tower 16Rajendra Place New Delhi - 110 008. The immediate object ofthe Company is to set up a project to manufacturelaboratory chemicals consisting of Peptones Extracts andDehydrated Culture Media for micro-biology and tissueculture. As the Company is setting up manufacturingfacilities for high purity chemicals for the first time inIndia under one roof with modern R & D facilities to caterthe national as well as international market and requiredcomplete infrastructure facility including importanttesting equipments to give the quality products requiredfor industries research fields public health care etc.pending the creation of manufacturing facilities theCompany could not start production.
Titan Bio-Tech Management
| Name | Position |
|---|---|
| Mr. Rohit Jain | Chairman & Ind.Director |
| Mr. Naresh Kumar Singla | Managing Director |
Titan Bio-Tech Similar Stocks
Bharat Rasayan Ltd.
1408.00
103.05 (7.90%)
Cropster Agro Ltd.
5.97
0.25 (4.37%)
Thirumalai Chemicals Ltd.
174.05
-5.50 (3.06%)
Jain Irrigation Systems Ltd.
29.57
0.14 (0.48%)
Pix Transmissions Ltd.
1458.30
-5.35 (0.37%)
Camlin Fine Sciences Ltd.
103.10
1.53 (1.51%)
Apollo Pipes Ltd.
434.00
5.65 (1.32%)
Paushak Ltd.
402.35
17.20 (4.47%)
Apcotex Industries Ltd.
352.75
6.30 (1.82%)
Nilkamal Ltd.
1220.00
72.50 (6.32%)
Titan Bio-Tech FAQs
